logo
Select company
Select metric
7.46%Operating Cash Flow Margin
VS
Market
44
Sector
71
Industry
53
History
78
$ 0.38Close
$ 0.28 - $ 2.82 52-Week Range
Ticker Information

Ticker

HBIO

Company Name

HARVARD BIOSCIENCE INC

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NASDAQ

HARVARD BIOSCIENCE INC - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

HBIO - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
6/30/2025$ 6.62M7.46%$ 88.75M
3/31/2025$ 3.02M3.31%$ 91.4M
12/31/2024$ 1.44M1.53%$ 94.14M
9/30/2024$ 4.02M4.11%$ 97.73M
6/30/2024$ 9.22M9.12%$ 101.13M
3/31/2024$ 13.62M12.75%$ 106.79M
12/31/2023$ 14.03M12.5%$ 112.25M
9/30/2023$ 12.4M11.02%$ 112.52M
6/30/2023$ 8.69M7.62%$ 114.08M
3/31/2023$ 4.95M4.32%$ 114.53M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • HARVARD BIOSCIENCE INC's latest trailing twelve months (TTM) OCF % stands at 8.88%.
  • Over the past 5 years, HARVARD BIOSCIENCE INC's average OCF % has been 5.22%.
  • The median OCF % for HARVARD BIOSCIENCE INC during this period was 4.81%
  • HARVARD BIOSCIENCE INC reached its highest OCF % over the past 5 years at 12.75%.
  • The lowest OCF % recorded by HARVARD BIOSCIENCE INC in the same timeframe -2.25%

HARVARD BIOSCIENCE INC's OCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCF % Benchmarks
CompanyOCF %
RVP : RETRACTABLE TECHNOLOGIES INC -31.55%NXGL : NEXGEL INC -24.69%ADAP : ADAPTIMMUNE THERAPEUTICS PLC -291.97%NSYS : NORTECH SYSTEMS INC -3.03%BNGO : BIONANO GENOMICS INC -95.03%AYTU : AYTU BIOPHARMA INC -2.92%IRIX : IRIDEX CORP -11.77%COSM : COSMOS HEALTH INC -8.15%NEPH : NEPHROS INC 11.97%EKSO : EKSO BIONICS HOLDINGS INC -62.24%

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for HARVARD BIOSCIENCE INC is calculated as follows: CF - Operations [ $ 9.06M ] / Revenues [ $ 102.09M ]
(=) OCF % [ 8.88% ]

HBIO - Operating Cash Flow Margin, Last 5 years

-2.25%

Minimum

Jun 30, 2022

12.75%

Maximum

Mar 31, 2024

5.22%

Average

4.81%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.31% with a standard deviation of 21.13%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max77.08%
average14.31%
median12.65%
std21.13%